Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of High-Dose Quadrivalent Influenza Vaccine versus Standard-Dose on Innate Immunity in Adults ≥65 Years
2021-004573-32Phase 4Completed
- Sponsor
- Centre Hospitalier Annecy Genevois
- Start
- Aug 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of influenza vaccine (quadrivalent, high-dose) and quadrivalent influenza vaccine in influenza (2 arms), sponsored by Centre Hospitalier Annecy Genevois. Primary endpoints: Innate immune response measures and Gene expression profiling. Started Aug 2021; status: completed.
02
Drugs
influenza vaccine (quadrivalent, high-dose)quadrivalent influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2021-004573-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-004573-32.